Recent Updates
Recently added Catalysts
ABBV Positive Sentiment

AbbVie to Present at the 41st Annual J.P. Morgan Healthcare Conference AbbVie (NYSE: ABBV) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023. Richard A. Gonzalez, chairman ...

Tuesday, January 3, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: AbbVie will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023, with CEO Richard A. Gonzalez presenting. The event underscores AbbVie's dedication to innovation in therapeutics across multiple medical areas. A live audio webcast will be accessible for broader audience engagement, alongside an archived edition available later the same day. This conference is significant for stakeholders and investors interested in AbbVie's developments.
Price reaction · baseline $161.61 (2022-12-30 close) · hit after-hours · 2 other ABBV headline(s) in the window, move may be shared
day 0 close · peak
+0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • AbbVie will present at a prestigious event, showcasing its commitment to innovation.
  • The company highlights its mission to address significant health challenges.
  • The availability of a live and archived webcast increases transparency and accessibility.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+33%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
paricalcitol
Phase 3 · Secondary Hyperparathyroidism

Full Press Release Details

NORTH CHICAGO, Ill. , Jan. 3, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV ) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 . Richard A. Gonzalez , chairman and chief executive officer, will present at 5:00 p.m. CT .
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com . An archived edition of the session will be available later that day.
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, and women's health, in addition to products and services across our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter , Facebook , Instagram , YouTube and LinkedIn .

Frequently Asked Questions

When is AbbVie presenting at the J.P. Morgan Healthcare Conference?

AbbVie will present on January 10, 2023, at 5:00 p.m. CT.

Where can I watch AbbVie's presentation?

The presentation will be accessible via AbbVie's Investor Relations website.

What is AbbVie's mission?

AbbVie's mission is to discover innovative medicines for serious health issues.

What therapeutic areas does AbbVie focus on?

AbbVie focuses on immunology, oncology, neuroscience, and women's health.

How can I find more information about AbbVie?

Visit AbbVie's website at www.abbvie.com for more information.

ShareAdd on Google
Tags: ABBV Viatris Investor Conferences Healthcare AbbVie J.P. Morgan healthcare conference Richard A. Gonzalez biopharma
Last updated: Jan 3, 2023

Biotech snapshot

Cash runway
$6569M liquidity · $0M/mo burn
Low dilution risk
Lead asset
paricalcitolPhase 3
Secondary Hyperparathyroidism →

Catalyst track record

+33%
best trade around ABBV's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for ABBV.

See every catalyst's timing & PoA →